Gilead’s investigational antiretroviral Quad regimen meets 48-week primary objective in pivotal Phase 3 Clinical Study 102
15 August 2011 | By Gilead Sciences
Phase 3 clinical trial met its primary objective...
List view / Grid view
News
“Drug hunter” honoured
11 August 2011 | By University of Brighton
One of the world’s most renowned “drug hunters” has been awarded an honorary Doctor of Science from the University of Brighton...
Abbott receives U.S. FDA approval for RX Herculink Elite® Renal Stent System
10 August 2011 | By Abbott
The U.S. FDA approved the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis...
GSK and Enigma Diagnostics announce collaboration
10 August 2011 | By GlaxoSmithKline
GSK & Enigma Diagnostics have signed agreements for the supply & commercialisation of the Enigma® ML system...
Greenphire contracts with the University of Kansas to automate clinical payment and communication processes
10 August 2011 | By The Scott Partnership
The University of Kansas (KU) implement Greenphire's patent-pending ClinCard System...
Boehringer Ingelheim licenses ProBioGen’s novel GlymaxX® technology
10 August 2011 | By Boehringer Ingelheim
Boehringer Ingelheim and ProBioGen AG have signed a non-exclusive Licensing Agreement regarding ProBioGen’s GlymaxX® technology...
U.S. FDA approves Gilead Sciences’ Complera™
10 August 2011 | By Gilead Sciences Inc
A new complete once-daily, single-tablet regimen for HIV-1 infection in treatment-naïve adults...
Lilly announces review of data on long-term raloxifene treatment
9 August 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published...
Biogen Idec and Abbott announce positive top-line results
9 August 2011 | By Abbott
Biogen Idec and Abbott announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial...
PRECOS partners with Reliable Cancer Therapies
9 August 2011 | By The Scott Partnership
PRECOS, has signed a partnership agreement with RCT to provide scientific validation of existing data for cancer therapies...
Regulatory update: GSK and XenoPort submit supplemental new drug application to FDA
9 August 2011 | By GlaxoSmithKline
GSK and XenoPort, Inc. request approval of Horizant™...
Positive first half-year 2011 for Boehringer Ingelheim
9 August 2011 | By Boehringer Ingelheim
The pharmaceutical company Boehringer Ingelheim has in the first half of 2011 once again grown in local currency terms compared to the previous year (+ 4 percent). Due to negative foreign exchange effects, consolidation in euros shows growth of 2.6 percent, with total net sales of EUR 6.4 billion against…
Gilead Sciences to purchase biologics process research and clinical manufacturing facility from Genentech
8 August 2011 | By Gilead Sciences Inc
Gilead Sciences, Inc. has signed a definitive agreement...
Pfizer expands California Centers For Therapeutic Innovation
8 August 2011 | By Pfizer
Five year partnership With UC San Diego Health Sciences to accelerate drug discovery and development...
Nikin Patel recognized as one of 100 most inspiring people in the life sciences industry
5 August 2011 | By The Scott Partnership
Molecular Profiles, a leading provider of pharmaceutical development services, has announced that Nikin Patel, CEO, has been acknowledged as one of PharmaVOICE magazine’s top 100 most inspiring individuals in the life sciences industry...
